Bruce & Co., Inc. Lava Therapeutics Nv Call Options Transaction History
Bruce & Co., Inc.
- $203 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
28KPut Options Held
43.4K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.84 Million0.27% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$680,0260.19% of portfolio
-
Walleye Capital LLC Plymouth, MN155KShares$286,1320.0% of portfolio
-
Alpha Wave Global, LP New York, NY108KShares$199,6260.2% of portfolio
-
Two Sigma Investments, LP New York, NY82KShares$151,7570.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $47.7M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...